Targeting autophagy and immunotherapy with hydroxychloroquine and interleukin 2 in patients with metastatic renal cell carcinoma (mRCC): A Cytokine Working Group study.

Authors

Leonard Appleman

Leonard Joseph Appleman

University of Pittsburgh Medical Center, Pittsburgh, PA

Leonard Joseph Appleman, Theodore F. Logan, Daniel Paul Normolle, Marc S. Ernstoff, Rahul Atul Parikh, David F. McDermott, Paul Monk, Thomas Olencki, David Friedland, Jodi Kathleen Maranchie, Lisa Helene Butterfield, Xiaoyan Liang, Michael T. Lotze

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO-SITC Clinical Immuno-Oncology Symposium

Session Type

Poster Session

Session Title

Poster Session B

Track

Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Breast and Gynecologic Cancers,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Oncolytic Viruses,Hematologic Malignancies

Sub Track

Biomarkers and Inflammatory Signatures

Clinical Trial Registration Number

NCT01550367

Citation

J Clin Oncol 36, 2018 (suppl 5S; abstr 106)

DOI

10.1200/JCO.2018.36.5_suppl.106

Abstract #

106

Poster Bd #

G3

Abstract Disclosures

Similar Posters

First Author: Leonard Joseph Appleman

First Author: Leonard Joseph Appleman

Poster

2014 ASCO Annual Meeting

NY-ESO-1 specific CD4<sup>+</sup> T<sub>helper</sub>1 cells for immunotherapy of cancer.

NY-ESO-1 specific CD4+ Thelper1 cells for immunotherapy of cancer.

First Author: Simone Kayser

First Author: J. Eva Selfridge